Acadia Healthcare Reports Mixed Q1: Strong Revenue Growth Offset by 51% Net Income Decline Amid Legal Costs & High Tax Rate
ACHC has more than doubled off its 52-week low of $11.43.
Summary
Acadia Healthcare reported strong Q1 revenue growth and increased operating cash flow, but GAAP net income and diluted EPS fell sharply due to higher legal settlement expenses and a significantly increased effective tax rate.
Key Events · Earnings and Guidance · ACHC
-
Strong Revenue Growth
Revenue increased by 7.6% to $828.8 million for the three months ended March 31, 2026, compared to $770.5 million in the prior year period. Same facility revenue grew by 7.3%.
-
Significant Net Income and EPS Decline
Net income attributable to Acadia Healthcare Company, Inc. decreased by 51% to $4.1 million, and diluted earnings per share fell by 44.4% to $0.05 for Q1 2026, compared to $8.4 million and $0.09, respectively, in Q1 2025.
-
Increased Operating Cash Flow
Net cash provided by operating activities significantly increased to $61.5 million in Q1 2026, up from $11.5 million in Q1 2025, partly due to $31.5 million in insurance proceeds from the 2019 Securities Litigation.
-
Higher Legal Settlements Expense
Legal settlements expense rose to $13.8 million in Q1 2026, including an uninsured portion of $13.8 million related to the Sandoval Litigation, compared to $3.5 million in Q1 2025.
Analysis · ACHC · Industrial Applications And Services
Acadia Healthcare's Q1 2026 results present a mixed financial picture. While the company achieved robust revenue growth and a significant increase in operating cash flow, its GAAP net income and diluted EPS saw substantial declines. This divergence is primarily attributed to a notable increase in legal settlements expense, particularly an uninsured portion of the Sandoval Litigation, and a significantly higher effective tax rate due to non-deductible executive compensation and valuation allowances. Investors should weigh the positive operational performance against these bottom-line pressures and the ongoing government investigations, which introduce considerable uncertainty regarding future liabilities.
At the time of this filing, ACHC was trading at $26.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $11.43 to $28.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.